URI Today

Tuesday, December 11, 2012

Pharmacy researcher finds most popular weight-loss drug alters drug therapy

uri today feature photo
Michael Salerno

A University of Rhode Island pharmacy researcher has discovered that the weight-loss drug orlistat, known by the brand names Xenical and Alli, inhibits a key enzyme that may lead to “severe toxicity of internal organs such as the liver and kidney.” The inhibition is irreversible and can be caused by a low level of the drug.

Professor Bingfang Yan’s study funded by the National Institutes of Health, also found that the drug alters efficacy of medicines, and particularly limits the effectiveness of some anti-cancer drugs.

“Since it has been available over–the-counter, there has been a drastic increase of toxicity among patients using the drug,” Yan said. “It has been linked to severe liver failure...


More Top Stories

Physical therapist offers advice on how to avoid holiday aches : A mountain of snow is behaving badly on your front steps. You can grab a shovel and go at it like a frenzied ditch digger. Or you can heed the advice of University of Rhode Island physical therapist John McLinden: baby scoops, even if it takes all day.

Oceanography student uses crashing waves to study Earth’s interior : A University of Rhode Island graduate student is using the tiny seismic waves created by ocean waves crashing on shorelines around the world to learn how an underwater plateau was formed 122 million years ago

President of Doctors Without Borders is final Honors Colloquium speaker, Dec. 10 : Unni Karunakara, international president of Doctors Without Borders, is the last speaker of the University of Rhode Island’s Honors Colloquium, which examines the politics and money influencing health care around the world.

See yesterday's URI Today